Magnesium-enriched coronary sinus retroperfusion during acute coronary artery occlusion

Coronary Artery Disease

Volumn 13, Issue 6, 2002, Pages 331-336

  Katircioǧlu, S Fehmi ^a   Ulus, A Tulga ^a   Saritaş, Zülfikar ^b   Aksöyek, Ayşen ^a   Tütün, Ufuk ^a   Apaydin, Nusret ^b   Pamuk, Kamuran ^c   Özgencil, Eser ^b   Koç, Bahattin ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c University of Ankara ^*

Author keywords

Acute coronary artery occlusion; Magnesium enriched retrograde coronary sinus perfusions

Indexed keywords

MAGNESIUM SULFATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; HEART INDEX; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMICS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUNG CAPILLARY PRESSURE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ACUTE DISEASE; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CORONARY CIRCULATION; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; DOGS; MAGNESIUM SULFATE; MODELS, CARDIOVASCULAR; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0036760037     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200209000-00005     Document Type: Article

References (44)

1. Ferrari R, Curello S, Cargnoni A. Metabolic changes during post-ischaemic reperfusion. J Mol Cell Cardiol 1988; 20:119-133.
2. Katircioǧlu SF, Küçükaksu DS, Gökçe P, Özgencil E, Taşdemir O, Bayazit K. Coronary sinus retroperfusion combined with intra-aortic balloon pumping to perfuse the acutely ischaemic myocardium. Thorac Cardiovasc Surgeon 1994; 42:330-332.
3. Kar S, Drury JK, Hajduczki I, Eigler N, Wakida Y, Litvack F, et al. Synchronized coronary venous retroperfusion for support and salvage of ischaemic myocardium during elective and failed angioplasty. J Am Coll Cardiol 1991; 18:271-282.
4. Lincoff AM, Popma JJ, Ellis SG, Vogel RA, Topol EJ. Percutaneous support devices for high risk or complicated coronary angioplasty. J Am Coll Cardiol 1991; 17:770-780.
5. Leung WH. Coronary and circulatory support strategies for percutaneous transluminal coronary angioplasty in high-risk patients. Am Heart J 1993; 125:1727-1738.
6. Mohl W. The relevance of coronary sinus interventions in cardiac surgery. Thorac Cardiovasc Surgeon 1991; 39;245-250.
7. Martin JS, Byrne JG, Ghez OY, Sayeed-Shah U, Grachev SD, Laurence RG, et al. LV-Powered coronary sinus retroperfusion reduces infarct size in acutely ischaemic pigs. Ann Thorac Surg 2000; 69:84-89.
8. Lazaar HL. Coronary sinus interventions during cardiac surgery. Ann Thorac Surg 1988; 46:475-482.
9. Christensen CW, Reider MA, Silverstein EL, Gencheff NE. Magnesium sulphate reduces the myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 1995; 92:2617-1621.
10. Reinhart RA. Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. Am Heart J 1991; 121:1513-1521.
11. Headrick JP, McKirdy JC, Willis RJ. Functional and metabolic effects of extracellular magnesium in normoxic and ischaemic myocardium. Am J Physiol 1998; 275:H917-H929.
12. Rassmusen HS, Norregard P, Lindeneg O, McNair P, Backer V, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet 1986; 1:234-236.
13. Salem M, Munoz R, Chernow B. Hypomagnesemia in critical illness. Crit Care Clin 1991; 7:225-252.
14. Burch GE, Giles TD. The importance of magnesium deficiency in cardiovascular disease. Am Heart J 1977; 94:649-657.
15. Ebel H. Role of magnesium in cardiac disease. J Clin Chem Clin Biechem 1983; 21:249-265.
16. Agus ZS, Wassertein A, Geldfarb S. Disorders of calcium and magnesium homeostasis. Am J Med 1982; 72:473-488.
17. Kugiyama K, Yasue H, Okumara K. Suppression of exercise induced angina by magnesium sulfate in patients with variant angina. J Am Coll Cardiol 1988; 12:1177-1183.
18. Thandroyen FT, Bellotto D, Katayama A, Hagler HK, Willerson JT, Buja LM. Subcellular electrolyte alterations during progressive hypoxia and following re-oxygenation in isolated neonatal rat ventricular myocytes. Circ Res 1992; 71:106-119.
19. Romani A, Scarpa A. Hormonal control of Mg transport in the heart. Nature 1990; 346:841-844.
20. Remani A, Marfella C, Scarpa A. Regulation of magnesium uptake and release in the heart and in isolated ventricular myocytes. Circ Res 1993; 72:1139-1148.
21. Woods KL. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 1991; 32:3-10.
22. Granger DN. Role of xanthine oxidase and granulocytes in ischaemia and reperfusien injury. Am J Physiol 1988; 24:H1269-H1275.
23. McGarrity ST, Stephenson AH, Webster RO. Regulations of human neutrophil function by adenine nucleotides. J Immunol 1989; 142;1986-1994.
24. White RE, Hartzell HC. Magnesium ions in cardiac function. Biocham Pharmacol 1989; 38:859-864.
25. Myoshi K, Taniguchi M, Seki S, Mochizuki S. Effects of magnesium and its mechanism on the incidence of reperfusion arrhythmias following severe ischaemia in isolated rat hearts. Cardiovasc Drugs Ther 2000; 14(6);625-633.
26. Shechter M, Sharir M, Labrador MJP, Forrester J, Silver B, Merz NB. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000; 102: 2353-2358.
27. Korthuis RJ, Grisham MB, Zimmerman BJ, Granger DN, Taylor AE. Vascular injury in dogs during ischaemia-reperfusion: Improvement with ATPMgCI2 pre-treatment. Am J Physiol 1998; 254(4 pt 2): H702-H708.
28. Kharb S, Singh V. Magnesium deficiency potentiates free radical production associated with myocardial infarction. J Assoc Physicians India 2000; 48(5):484-485.
29. Katircioǧlu SF, Küçükaksu S, Bozdayi M, Taşdemir O, Bayazlt K. Beneficial effects of prostacyclin treatment on reperfusion of the myocardium. Cardiovasc Surg 1995; 3:405-408.
30. Katircioǧlu SF, Taşdemir O, Bayazit K. Coronary sinus retroperfusion with a simple method. Ann Thorac Surg 1997; 63:1210.
31. Uzunonat G, Emir M, Yamak B, Ulus AT, Ulaş M, Uncu H, et al. Coronary snus retroperfusion during acute experimental coronary artery occlusion. J Cardiovasc Surg 1999; 40:197-201.
32. Katircieǧlu SF, Ulus AT, işcan Z, Yamak B, Saritaş Z, Birincioǧlu L. Preservatien of myocardial metabolism in acute coronary artery occlusions with retrograde coronary sinus perfusion and iloprost. Prostaglandins, Leukotriens and Essential Fatty Acids 1998; 59:169-174.
33. Katircioǧlu SF, işcan Z, Ulus AT, Saritaş Z. Myocardial preservation in acute coronary artery occlusion with coronary sinus retroperfusion and carnitine. J Cardiovasc Surg 2000; 41:45-50.
34. Kar S, Nordlander R. Coronary veins: An alternate route to ischaemic myecardium. Heart Lung 1992; 21:148-159.
35. Feld S, Ekas RD, Felli P, Amirian J, Smalling RW. Differential effects of synchronized coronary sinus retroperfusion on regional myocardial function during brief occlusion of the left anterior descending and circumflex coronary arteries. Cathet Cardiovasc Diagn 1994; 32:70-78.
36. Incorvati RL, Tauberg SG, Pecora MJ, Macherey RS, Krucoff MW, Dianzumba S, et al. Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993; 22:127-134.
37. O'Byrne GT, Nienaber CA, Miyazaki A, Araujo L, Fishbein MC, Corday E, et al. Positron emission tomography demonstrates that coronary sinus retroperfusion can restore regional myocardial perfusion and preserve metabolism. J Am Coll Cardiol 1991; 18: 257-270.
38. Von Lüdinghausen M, Chiba S, Ohmachi N. The venous drainage of the myocardium in the human heart. In: Mohl W (editor): Coronary Sinus Interventions in Cardiac Surgery. Austin: R.G. Landes Company, 1994. pp. 11-16.
39. Chaudry IH. Cellular mechanisms in shock and ischaemia and their correction. Am J Physiol 1983; 245:R117-R120.
40. Forman MB, Virmani R, Puett DW. Mechanisms and therapy of myocardial reperfusion injury. Circulation 1990; 81(suppl IV):IV69-IV78.
41. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischaemic myocardium. J Pharmacol Methods 1985; 14:157-167.
42. Ytrehus K, Myklebust R, Mjost OD. Influence of oxygen radicals generated by xanthine oxidase in the isolated perfused rat heart. Cardiovasc Res 1986; 20:597-603.
43. Hess ML Eaton NH, Manson NH. Hydrogen peroxide and hydroxyl radical mediation of activated neutrophil induced canine mechanical dysfunction. J Mol Cell Cardiol 1986; 18(suppl 1):70.
44. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70:427-451.